<a href=/RCL/BAN/009/?lnk=yes target=_blank><img src=/RCL/BAN/009/141014_1.gif width=1050 height=60 border=0></a>
Subscription and demo access


 
About Interfax
Press Releases
Products & Services
Contact Us
Customer Login
 


Headlines
 

12/22 16:19   Moscow to respond to Washington's anti-Crimean sanctions - Ushakov (Part 2)
 
12/22 16:18   Gazprom exports to fall to 147 bcm in 2014 from 162 bcm in 2013 (Part 2)
 
12/22 16:17   PUTIN TO HOLD BILATERAL MEETINGS WITH NAZARBAYEV, ATAMBAYEV DURING CSTO, EEU SUMMITS, NO AGREEMENT OVER SEPARATE MEETING WITH LUKASHENKO - USHAKOV
 
12/22 16:16   Many world leaders invited to V-Day festivities in Moscow - Ushakov (Part 2)
 
12/22 16:16   No grounds to postpone tax maneuver in oil industry - Novak
 
12/22 16:15   Moscow interbank Ruonia rate and volume of the transactions used to calculate the rate
 
12/22 16:14   Novak: Oil price lower than $50 a barrel - sufficiently negative for Russian oil sector (Part 2)
 
12/22 16:11   Rusal, partners discussing timing of Boguchany smelter launch
 
12/22 16:08   Accumulation of forex revenue by exporters is legal
 
12/22 16:06   Kremlin expects N. Korea leader to visit Moscow for Victory Day celebrations (Part 2)
 




 

Interfax.com  |  Interfax news  |  FAS green-lights AFK Sistema bid to buy 100% of...


News headlines


November 12, 2012 15:08

FAS green-lights AFK Sistema bid to buy 100% of VeroPharm, but with terms (Part 2)

MOSCOW. Nov 12 (Interfax) - Russia's Federal Antimonopoly Service (FAS) has approved AFK Sistema's (RTS: AFKS) request for permission to buy 100% of the stock in pharmaceuticals company OJSC VeroPharm (RTS: VRPH), but has attached some terms, a FAS statement says.

The FAS established that VeroPharm has a dominating position on the market for medicines with MNN Gemifloksatsin, and its subsidiary LLC LENS-Pharm with MNN Poliadenilovaya Kislota + Poliuridilovaya Kislota.

The FAS takes the view that the conduct of this deal could lead to a limiting of access to the market for the sale of these medical preparations by independent counteragent VeroPharm and LENS-Pharm. In light of this, the FAS requires of Sistema and VeroPharm to ensure the fulfillment of all contracts for the delivery of all medicines existing on the date the deal is completed.

Before the deal is done, Sistema is to post on its official website the document regulating its commercial policy as regards VeroPharm medical preparations, and announce changes to commercial policy in letter form to the FAS within thirty days.

The parties are not to, from the date the deal is completed, effect any unfounded economic or technological reduction or halt of the production and supply of goods that are still in demand. They are also to announce to the FAS either of such circumstances in letter form within thirty days.

AFK Sistema and VeroPharm are to annually inform the FAS in letter form that they are meeting these conditions.

The parties to the deal are to announce its completion to the anti-monopoly agency within twenty days from the day the deal is wrapped up.

According to DSM Group data, VeroPharm is third in a rating of the largest Russian pharmaceutical companies. Company product is provided by three plants: in Belgorod, Voronezh, and Pokrov. VeroPharm specializes in the production of Rx medical goods, which account for about 70% of its sales revenues.

Pharmacy Chain 36.6 (RTS: APTK) owns 51.8% of the company.

Cf

(Our editorial staff can be reached at eng.editors@interfax.ru)

/Interfax/
 Subscription
You can access a demo version of, receive more information about or subscribe to Interfax publications by filling in and returning the form below. We also have dozens of reports in the Russian language, please indicate if you are interested.
Title:


Phone:


E-mail:


First name:


Company:


Country:
Last name:


Division:


City:
Products:
Central Asia & Caucasus Business Weekly
Central Asia General Newswire
Global Gas Analytics
Global Natural Gas Daily
Interfax Via Bloomberg Terminal
Kazakhstan General Newswire
Kazakhstan Mining Weekly
Kazakhstan Oil & Gas Weekly
Russia & CIS Announcements
Russia & CIS Banking and Finance Weekly
Russia & CIS Business and Financial Daily
Russia & CIS Business and Financial Newswire
Russia & CIS Business and Investment Weekly
Russia & CIS Business Law Weekly
Russia & CIS Business news
Russia & CIS Defense Industry Weekly
Russia & CIS Diplomatic Panorama
Russia & CIS Energy Daily
Russia & CIS Energy Newswire
Russia & CIS Events Calendar
Russia & CIS Food and Agriculture Weekly
Russia & CIS General Newswire
Russia & CIS Headline News
Russia & CIS Insurance Weekly
Russia & CIS IT and Telecom Weekly
Russia & CIS Metals and Mining Weekly
Russia & CIS Military Daily
Russia & CIS Military Newswire
Russia & CIS Military Weekly
Russia & CIS Oil and Gas Weekly
Russia & CIS Presidential Bulletin
Russia & CIS Statistics Weekly
Russia Health & Pharmaceuticals
Russia Market Roundup
Russia Press Review
Ukraine Business Daily
Ukraine Business Weekly
Ukraine General Newswire
Please enter the digits from picture in the box below:

December 22, 2014
 
16:11
Rusal, partners discussing timing of Boguchany smelter launch
 
16:08
Accumulation of forex revenue by exporters is legal
 
16:06
Kremlin expects N. Korea leader to visit Moscow for Victory Day celebrations (Part 2)
 
16:05
Kremlin expects N. Korea leader to visit Moscow for Victory Day celebrations
 
16:05
RusHydro plans system-wide cost cutting
 
16:05
Moscow to respond to Washington's anti-Crimean sanctions - Ushakov
 
16:05
Many world leaders invited to V-Day festivities in Moscow - Ushakov
 
16:04
 
16:03
Moscow not planning Assad visit - Ushakov
 
16:03
Kremlin expects N. Korea leader to visit Moscow for Victory Day celebrations
 
16:03
Putin to speak to French, German, Ukrainian presidents in "Normandy format" - Ushakov
 
16:02
Corrected: Rusal paid $20 mln on syndicated loan in Nov, next payment in Dec - CFO
 
16:01
Possibility of contact between Putin, Obama in first half of 2015 not currently being discussed - Ushakov
 
16:01
Putin to speak to French, German, Ukrainian presidents in "Normandy format" - Ushakov
 
 more headlines 



Interviews
 

.
Germany‘s E.ON is spinning its Russian business off to a "New Company" which will be transferred to the company‘s shareholders, with plans to list it in 2016. Apart from the Russia business, the new company will receive all of E.ON‘s conventional energy assets. E.ON itself will focus on renewable energy and innovation. Johannes Teyssen, E.ON‘s CEO, told Interfax in an interview of the logic behind the decision and its implications for the concern‘s Russian subsidiary OJSC E.ON Russia.

more
.
.
Australian Ambassador to Russia Paul Myler has given an interview to Interfax ahead of the G20 summit in Brisbane in which he speaks about the MH17 crash, the reasons for joining the West‘s sanctions against Russia and explained why Australia expects changes in Russia‘s food policy by March 2015.

more
.
.
The name Arkady Rotenberg has been in the news far more frequently than usual in recent months. The billionaire was hit by the first wave of European Union sanctions against Russia, and has already challenged this decision in court. Recently it was reported that the businessman has sold part of his assets to his eldest son. Arkady Rotenberg spoke in an interview with Interfax about whether there was a link between these two developments, the impact of sanctions on his business, his friendship with President Vladimir Putin and many other topics.

more

 
  
 ©   1991—2014   Interfax Information Service. All rights reserved.
contact information   |   Interfax offices   |   made by web.finmarket

News and other data on this site are provided for information purposes only, and are not intended for republication or redistribution. Republication or redistribution of Interfax content, including by framing or similar means, is expressly prohibited without the prior written consent of Interfax.

Browse other Interfax sites:  Interfax.ru   |   IFX.RU   |   Interfax Group   Rambler's Top100